CIK 0001655759
- Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472566120
- Phone
- +1 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- 4 Open-market sale Chief Accounting Officer sold 460 shares at an average $22.39 ($10,301)
- 4 Grant or award Chief Financial Officer acquired 61,409 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Scientific Officer acquired 15,995 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 5,899 shares (grant or award)
- 4 Grant or award Director acquired 5,899 shares (grant or award)
- 4 Grant or award Director acquired 5,899 shares (grant or award)
- 4 Grant or award Director acquired 5,899 shares (grant or award)
- 4 Grant or award Director acquired 5,899 shares (grant or award)
- 4 Grant or award Director acquired 5,899 shares (grant or award)
- 4 Grant or award Director acquired 5,899 shares (grant or award)
- 4 Grant or award Director acquired 5,899 shares (grant or award)
- 4 Grant or award Int. Chief Financial Officer acquired 13,300 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 63,452 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 5,196 shares at $47.05 ($244,472)
- 4 Open-market sale Chief Financial Officer sold 1,702 shares at $47.05 ($80,079)
- 4 Open-market sale Chief Medical Officer sold 1,699 shares at $47.05 ($79,938)
Page 4 of 15 · 285 filings